Picard Medical/ SynCardia to Present at European Mechanical Circulatory Support Summit and International Course on Mechanical Circulatory Support and New Technologies in Heart Failure

Core Insights - Picard Medical, Inc. is set to present data on its fully implantable Emperor Total Artificial Heart at the upcoming 19th EUMS & 11th International Course on MCS and New Technologies in Advanced Heart Failure congress in Barcelona, Spain from February 15-18, 2026 [1][2] Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is the only provider of commercially available total artificial heart technology for patients with end-stage heart failure [3] - The SynCardia Total Artificial Heart (STAH) is the first artificial heart approved by both the U.S. FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada [3] - Over 2,100 implants of the SynCardia Total Artificial Heart have been performed in hospitals across 27 countries, making it the most widely used and extensively studied artificial heart globally [3] Event Details - The presentation titled "The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia's Electromechanical Total Artificial Heart" will take place on February 16, 2026, from 17:15 to 18:15 Central European Time [2] - The European Mechanical Circulatory Support Summit (EUMS) serves as a leading international forum for advancing mechanical circulatory support and emerging technologies in treating advanced heart failure [2]